Atossa Therapeutics ( ($ATOS) ) has issued an update. On January 6, 2026, Atossa Therapeutics announced that the U.S. Food and Drug Administration ...

Avenga, a global digital engineering and AI-driven software transformation specialist, today announced that Clay Van Doren ...

As of Wednesday, December 31, Atossa Therapeutics, Inc.’s ATOS share price has dipped by 9.72%, which has investors ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet medical needs, today announced that the U.S. Food and Drug Administration ...

Atossa Therapeutics (ATOS) announced that the U.S. FDA issued a “Study May Proceed” letter for the company’s study in metastatic breast cancer ...

Comparing Coloplast to ConvaTec, the latter has been seeing double-digit growth in China, where Coloplast has been struggling ...

THE regeneration of Whitehaven town centre will ‘enter a new phase’ in 2026 with the opening of a ‘captivating’ new £4.5m ...

AMD CEO Lisa Su says AI will soon need "10 yottaflops" of compute — a scale of computing power the world has never built ...

Recent New York decisions demonstrate a judicial trend toward enforcing contractual provisions negotiated between ...

Rising cloud storage costs, data lock-in and frequent outages are driving interest in decentralized alternatives, according ...